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Background: Skin tissue homeostasis is maintained by a balance between the proliferation and differentiation of
epidermal stem cells (EpSCs). EpSC proliferation and differentiation are complex processes regulated by many
factors and signaling pathways. This study aimed to explore the connection between the Nanog and the Wnt/β-
catenin pathway in the proliferation and differentiation of EpSCs.
Results: Our results demonstrated that during the study period, EpSC underwent differentiation when incubated in
the presence neuropeptide substance P (SP), there was an opposing expression trend of Nanog and β-catenin after
SP treatment, which could be antagonized by the Wnt antagonist, Dkk-1. The transduced EpSCs had a greater
proliferative ability than the SP treatment group and they did not undergo differentiation upon SP treatment. More
important, β-catenin expression was down-regulated but phosphorylated β-catenin expression and phosphorylated
GSK-3β expression was up-regulated upon Nanog overexpression.
Conclusions: These results strongly suggest that Nanog plays an important role in maintaining the proliferation
and differentiation homeostasis of EpSCs by promoting β-catenin phosphorylation via GSK-3β to inhibit the activity
of the Wnt/β-catenin signaling pathway. This is important for precise regulation of proliferation and differentiation
of EpSC in the application of tissue engineering.
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Skin is the largest organ of the human body; it plays a
key role in protecting the body against pathogens. The
homeostasis of skin tissue is maintained by rare but
pluripotent epidermal stem cells (EpSCs) and their pro-
geny, transient amplifying (TA) cells [1,2]. As pluripo-
tent cells, EpSCs not only have an unlimited self-renewal
capability to maintain a certain population but they also
differentiate to form structures such as hair follicles and
sebaceous glands [2,3].* Correspondence: wk-zhang@hotmail.com; 2007hh@gmail.com
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unless otherwise stated.Transcription factors and signals determine whether
EpSCs undergo self-renewal or differentiation. Several
studies have established the central role of Nanog in
maintaining pluripotency and preventing differentiation
[4-7]. Nanog simultaneously increases the expression of
genes conferring pluripotency and decreases the ex-
pression of genes driving cell differentiation. Increasing
evidence also supports the involvement of the Wnt/β-
catenin signaling pathway in the self-renewal and dif-
ferentiation of EpSCs [8-10]. β-catenin is of central
importance in the Wnt/β-catenin signaling pathway.
Numerous articles have also reported that the fate of
EpSC is controlled by an intricate relationship between
different signaling pathways and transcription factors,
especially Nanog and the Wnt/β-catenin signalingThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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been able to clearly reveal the underlying molecular mech-
anism of EpSC proliferation and differentiation. Thus, the
relationship between Nanog and the Wnt/β-catenin sig-
naling pathway in EpSC proliferation and differentiation is
of great interest.
In this study, we evaluated the relationship between the
Wnt/β-catenin signaling pathway and Nanog in the prolif-
eration and differentiation of EpSCs. Rat EpSCs were
infected with lentivirus overexpressing Nanog. SP,a neuro-
peptide present in primary sensory neurons,belongs to the
tachykinin family and can activate Wnt/β-catenin signal-
ing pathway [15]. Transduced or untransduced cells were
subsequently incubated in the presence or absence of SP.
The effect of Nanog and SP on EpSC proliferation was
tested in vitro. Subsequently, the expression of β-catenin
and Nanog were evaluated in SP treated EpSCs using
western blotting and PCR. In addition, the effect of Nanog
on β-catenin expression was investigated in EpSCs using a
lentivirus infection and/or SP treatment.Figure 1 Characterization of the isolated EpSCs. The morphology of th
positively express CD34 (B) and β1 integrin (C) as detected by immunofluoresc
spindle morphology. (E) CK18 expression in these SP-induced EpSCs indicated t
(F) Wnt agonist triggers EpSC differentiation, as demonstrated by CK18 immuno
EpSCs demonstrated that these cells were still stem cells, as detected by immun
EpSCs. (I) The transduced EpSCs did not undergo differentiation upon SP treatmResults
Characterization of EpSCs
Rat EpSCs were isolated using rapid substrate attach-
ment. Collagen type IV was used in this study to isolate
EpSCs because collagen type IV is the ligand of β1 integ-
rin, which is a potent cell marker of EpSCs. The rapidly
adherent cells demonstrated stem cell characteristics as
bird nest-like or slabstone-like (Figure 1A), which is the
typical morphology of EpSCs. The expression of CD34
and β1 integrin was examined by immunofluorescence.
Both CD34 (Figure 1B) and β1 integrin (Figure 1C) were
highly expressed in the isolated cells, which proved that
these isolated population were the EpSCs [16,17]. On
the other hand, EpSC differentiation was detected after
12 days of 10−7 M SP treatment or Wnt agonist treatment.
Differentiated EpSCs showed the special morphologies as
long spindle or polygonal (Figure 1D). Furthermore, differ-
entiated EpSCs expressed CK18, which are expressed in
the epithelial cells [18], as demonstrated by immunocyto-
chemistry (Figures 1E, 1F). However, Wnt antagonist Dkk-e isolated cells are bird nest-like or slabstone-like (A). The isolated cells
ence. (D) EpSCs treated with 10−7 M for 12 days showed polygonal or long
hese cells were differentiated, as demonstrated by immunocytochemistry.
cytochemistry. (G) CD34 positive expression in the SP with Dkk-1 treated
ofluorescence. (H) Fluorescence microscopy image of the transduced
ent. Scale bar =20 μm.
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positive expression in the SP with Dkk-1 treated EpSCs
(Figure 1G) indicated that these cells were not differenti-
ated. After infection with lentivirus-Nanog, EpSCs pro-
duced green fluorescence under a fluorescent microscope
(Figure 1H). The transduced EpSCs did not undergo dif-
ferentiation during the study period (Figure 1I).
Proliferative ability of EpSCs infected with lentivirus or
treated with SP in vitro
A450, which represents EpSC proliferative ability, was
tested at one-day intervals from day 2 to day 12 using a
CCK-8 kit. A strong linear increase in A450 between day
2 and day 12 was observed, indicating EpSC prolifera-
tion. The proliferative ability of EpSCs infected with
control lentivirus vector was similar to the control,
which had no significant difference at any time point.
However, the proliferative ability of transduced EpSCs
was much greater than the SP treatment group, control
lentivirus vector infected group, and control during the
study period. In addition, EpSCs treated with SP prolif-
erated faster than the control in the first 10 days; on day
12, the proliferative rate of SP treated group reached a
plateau while the control continued to rapidly proliferate
(Figure 2) (P < 0.05).
The expression of Nanog and β-catenin in EpSCs treated
with SP
To reveal change in expression of Nanog and β-catenin
in the EpSC differentiation process induced by 10−7 M
SP, we detected Nanog and β-catenin expression at the
mRNA and protein level every three days from day 0 to
day 12. q-PCR analysis revealed that Nanog expression
decreased. Nanog expression was significantly lower
from days 3–12 than at day 0 (P < 0.05). However, β-
catenin expression increased significantly from days 3–
12 compared to day 0 (P < 0.05) (Figure 3A). WesternFigure 2 Proliferative ability of EpSCs in vitro, as measured by
the CCK-8 assay.blot results were similar to q-PCR results (Figures 3B,
3C, 3D).
To confirm that the expression of Nanog and β-
catenin in the EpSC differentiation process induced by
10−7 M SP was related to Wnt/β-catenin signaling path-
way, we used a specific Wnt antagonist, Dkk-1, and then
detected Nanog and β-catenin expression at the mRNA
and protein level every three days from day 0 to day 12.
q-PCR analysis revealed that at any time on or after day
3 β-catenin expression was lower and Nanog expression
was higher in both SP and Dkk-1treatment group than
SP treatment group(P < 0.05) (Figure 4A and 4B). At day
12, protein of Nanog and β-catenin were also detected.
The western blotting results were in accordance with q-
PCR results. (P < 0.05) (Figures 4C, 4D and 4E).
The expression of Nanog and β-catenin in EpSCs infected
with lentivirus
To reveal the effect of Nanog overexpression on β-
catenin and confirm the lentivirus itself do not affect the
expression of Nanog or β-catenin, we infected EpSCs
with lentivirus loaded with or without Nanog. Nanog
and β-catenin expression at mRNA were detected at dif-
ferent time point (day 1- day 12) (Figures 5A and 5B).
The results of q-PCR revealed that Nanog expression in
the lentivirus-Nanog group increased remarkably at day
3, and continuely increased every day. However, β-
catenin expression decreased from day 3, which were
quite opposite to the Nanog expression. At day 12, protein
of Nanog and β-catenin were also detected (Figures 5C,
5D and 5E). Western blot results were similar to q-PCR
results. Besides, there were significant differences between
the transduced group and control both at mRNA and pro-
tein level. And more, there was no significant difference
between the control lentivirus vector infected group
and control at either mRNA or protein level (Figure 5)
(p < 0.05).
Negative feedback of Nanog on the Wnt /β-catenin
signaling pathway
To explore how Nanog affects the Wnt/β-catenin signal-
ing pathway, EpSCs infected with lentivirus encoding
Nanog were incubated in the presence or absence of SP.
Nanog, β-catenin and c-myc in Wnt/β-catenin signaling
pathway were detected both at mRNA and protein level.
At the mRNA level, Nanog expression in transduced
cells in the absence or presence of SP was significantly
higher than the control or SP-only treatment groups
(Figure 6A) (P < 0.05). In contrast to Nanog expression,
pt]?>β-catenin expression in transduced cells in the absence or
presence of SP was significantly lower than the control or SP-
only treatment groups (Figure 6B) (P<0.05). C-myc, a down-
stream gene in the Wnt/β-catenin signaling pathway, trended
with β-catenin expression (Figure 6C). The western blotting
Figure 3 Expression of β-catenin and Nanog in EpSCs treated with SP. β-catenin and Nanog were measured at different time points
(day 0-day 12) at the mRNA (q-PCR) and protein (western blot) level (A and B). The bands of each protein were quantitatively analyzed (C and D).
Both q-PCR and western blot analysis showed that β-catenin expression was significantly higher on or after day 3 than at day 0. Nanog and β-catenin
expression had an inverse relationship (*P < 0.05).
Figure 4 Expression of β-catenin and Nanog in EpSCs treated with Wnt antagonist, Dkk-1. Real-time PCR analysis of β-catenin mRNA (A)
and Nanog mRNA (B) were obtained at different time points (day 1- day 12) in the control, SP treated group and SP with Dkk-1 treated group.
The result showed that there were significant differences between the SP group and SP with Dkk-1 group on or after day 3 (*P < 0.05). At day 12,
protein of Nanog and β-catenin were also detected (C). The bands of both proteins in each group were analyzed quantitatively (D and E).
Werstern blot results were similar to q-PCR results (Con: control; SP: SP treated group; SP + Dkk-1: SP with Dkk-1 treated group).
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Figure 5 Expression of β-catenin and Nanog in EpSCs infected with lentivirus. Real-time PCR analysis of Nanog mRNA (A) and β-catenin
mRNA (B) were obtained at different time points (day 1- day 12) in the control, control lentivirus vector infected group and transduced group. The
results showed that there were no significant differences between the control and control lentivirus vector infected group. However, significant
differences existed in the transduced group with the control on or after day 3(*P < 0.05). At day 12, protein of Nanog and β-catenin were also detected
(C). The bands of both proteins in each group were analyzed quantitatively (D and E). Western blot results were similar to q-PCR results (Con: control;
LV: control lentivirus vector infected group; LV-Nanog: transduced group).
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and 6F).
To demonstrate the change in β-catenin expression in
detail, total β-catenin,phosphorylated β-catenin, total
GSK-3β protein and phosphorylated GSK-3β protein
were also measured using western blotting (Figure 7A).
Figure 7C shows that total β-catenin protein expression
was significantly higher in the control and SP treated
groups compared with transduced group in the absence
or presence of SP (P < 0.05). However, phosphorylated β-
catenin expression in EpSCs, which is inactivated β-
catenin, was significantly different compared with total
β-catenin protein expression (P < 0.05) (Figure 7D).
Phosphorylated β-catenin protein expression in the con-
trol and SP treated groups was significantly lower than
transduced cells in the absence or presence of SP. This
result is the opposite of the results obtained with total
β-catenin protein expression. Further analysis could be
obtained, the ratio of phosphorylated β-catenin to total
β-catenin was significantly high in transduced EpSCs
(Figure 7E) (P < 0.05). In addition, the ratio of phosphor-
ylated GSK-3β to total GSK-3β was another indicator of
inactivated β-catenin. With the intensity quantitative
analysis, it had a similar trendency with the ratio of
phosphorylated β-catenin to total β-catenin (Figure 7B)
(P < 0.05).
Discussion
As the primary barrier in the human body, skin protects
humans from infection, radiation and wounds. However,skin, especially the epidermis, may be injured by external
insults. The proliferation and differentiation of EpSCs
and their progeny of TA cells greatly affect skin repair
[2,19,20]. This process is controlled by an intricate rela-
tionship between different signaling pathways and tran-
scription factors, especially the Wnt/β-catenin signaling
pathway and Nanog [21-23].
Nanog is a pluripotent state-specific transcription fac-
tor that plays a critical role in regulating cell fate during
embryonic development, maintaining pluripotent epi-
blasts and preventing differentiation [24,25]. Nanog is
also proposed as a transcription repressor that inhibits
important genes for cell differentiation [7,26]. Our re-
sults showed that the proliferation ability of transduced
EpSCs is much greater than the control and SP treated
groups (Figure 2). Additionally, transduced EpSCs
treated with SP did not undergo differentiation (Figure 1I).
These results using EpSCs agree with previous reports
that Nanog can promote proliferation and inhibit dif-
ferentiation of stem cells. On the other hand, accu-
mulating evidence indicates that the Wnt/β-catenin
signaling pathway plays a critical role in the lineage de-
cision/commitment process [10,23,27,28]. In contrast,
there are also some reports that the Wnt/β-catenin sig-
naling pathway plays a pivotal role in the maintenance
of pluripotency as well as in the process of somatic cell
reprogramming [9,29-31]. These dramatically different
observations upon activation of the Wnt signaling
cascade have fueled enormous controversy concerning
the role of Wnt signaling in the maintenance of
Figure 6 Overexpression of Nanog inhibits the Wnt signaling pathway. Real-time PCR analysis of gene expression ((A) Nanog, (B) β-catenin,
and (C) c-myc) of the EpSCs in the control, SP-treated group, transduced group, and the combination treatment group. At the protein level,
Nanog, c-myc, and total β-catenin were also detected (D). The bands of Nanog and c-myc protein in each group were analyzed quantitatively
(E and F). (*P < 0.05) (Con: control; SP: substance P treated group; LV-Nanog: transduced group).
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Our results in EpSCs support the former conclusion. In
this study, EpSCs were differentiated when they were
treated with a Wnt agonist (Figure 1F) and the differen-
tiation was antagonized by Dkk-1(Figure 1G). This
result supports evidence that the Wnt/β-catenin signal
pathway affects EpSCs differentiation.
It is noteworthy that treatment with 10−7 M SP caused
a rapid proliferation of EpSCs into TA cells in the first
twelve days, which subsequently had a limited prolifera-
tive ability (Figure 2). This result agrees with our previ-
ous study regarding the effect of SP on EpSCs [32].
Previous reports also support our findings [33,34]. From
day 12, the EpSCs underwent differentiation, manifesting
the typical morphology and expressing CK18, which is
an EpSCs differential marker [35,36] (Figures 1D, 1E).
This is a new observation compared to our previous
research. In this process, the expression of the pluripo-
tency protein Nanog decreased significantly. However, β-
catenin transcription and translation increased (Figure 3).
Besides, the increase of β-catenin could be counteracted
by Dkk-1 (Figure 4). The opposing expression trends ofNanog and β-catenin suggested that there should be an
interaction between them (Figures 3 and 4).
To prove this hypothesis, we infected lentivirus-Nanog
into EpSCs in vitro (Figure 1H). CCK-8 results revealed
that the transduced EpSCs had a strong proliferative abil-
ity, while the control lentivirus vector infection showed no
effect on the EpSCs proliferative ability (Figure 2). Besides,
the control lentivirus vector infection also did not interfere
with Nanog and β-catenin expression either (Figure 5).
Nanog counteracted SP-induced cell differentiation
(Figures 1I and 6A). The most important result is that
β-catenin expression in the transduced EpSCs was not-
ably decreased as measured by q-PCR and western blot
(Figure 6). This result suggests that Nanog can inhibit
EpSC differentiation by inhibiting β-catenin expression.
C-myc, a downstream target of Wnt/β-catenin signaling
pathway, binds to promoter sequences after activation
by β-catenin-TCF complexes. Haegele et al. found that
the activation of c-myc and its downstream targets
Cyclin-dependent kinase 2 (CDK) and Cyclin A could
up-regulate BMPs and cause embryonic stem cell dif-
ferentiation [31]. In the SP-treated groups, c-myc
Figure 7 Overexpression of Nanog promotes β-catenin phosphorylation. The protein of total and phosphorylated GSK-3β,total and
phosphorylated β-catenin were detected (A). The ratio of phosphorylated GSK-3β to total GSK-3β was an indicator to inactivation of β-catenin
(B). The bands of β-catenin protein in each group were analyzed quantitatively (C and D). The ratio of phosphorylated β-catenin to total
β-catenin was regarded as the inactive β-catenin (E). (*P < 0.05) (Con: control; SP: substance P treated group; LV-Nanog: transduced group).
Cheng et al. Cell & Bioscience 2015, 5:5 Page 7 of 10
http://www.cellandbioscience.com/content/5/1/5expression of the transduced EpSCs was also sup-
pressed both at mRNA and protein level (Figures 6C,
6F). The change in c-myc expression agreed with β-
catenin changes in the transduced EpSCs, which indir-
ectly demonstrates that β-catenin is involved in EpSC
differentiation. This result further proved that Nanog
can maintain EpSC pluripotency and prevent differenti-
ation by inhibiting the β-catenin expression.
To explore the potential mechanism of this process, we
measured the levels of phosphorylated β-catenin protein,
phosphorylated GSK-3β and total GSK-3β in each group.
It is well known that the activity of the Wnt/β-catenin sig-
naling pathway is affected by glycogen synthase kinase
(GSK). GSK-3β is phosphorylated and results in β-catenin
phosphorylation and its subsequent degradation by the
ubiquitin-mediated pathway [29,37]. In this experiment,
we found that the ratio of phosphorylated β-catenin to
total β-catenin paralleled Nanog expression in each group
(Figure 7E), which is in common with the ratio of phos-
phorylated GSK-3β to total GSK-3β (Figure 7B). There-
fore, we conclude that Nanog inhibits β-catenin activity
through the phosphorylation of β-catenin via GSK-3β.
Thus, we can infer the underlying process by which EpSCs
execute their function. When skin is not injured, Nanogmaintains the multi-potential and proliferative state of
EpSCs through inhibiting β-catenin expression via β-
catenin phosphorylation. However, when skin needs to re-
pair an injury, negative feedback from β-catenin on Nanog
suppresses its expression and induces EpSC differenti-
ation. The whole process balances the differentiation and
proliferation of EpSCs.
Conclusion
In summary, our study showed that Nanog and the Wnt/
β-catenin signaling pathway are involved in the regulation
of EpSC proliferation and differentiation, which is neces-
sary to maintain EpSCs homeostasis in the skin. The
underlying mechanism is that Nanog inhibits the activity
of the Wnt/β-catenin signaling pathway via GSK-3β medi-
ated β-catenin phosphorylation. This finding represents an
important step towards understanding the precise regula-
tion of EpSC proliferation and differentiation, which has
important applications in tissue engineering.
Materials and methods
Cell culture
Sprague–Dawley (SD) male rats were purchased from
HUST Laboratory Animal Center (Wuhan, China). The
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University of Science and Technology, approved all ani-
mal care and experimental procedures. The EpSCs iso-
lated procedure was regarded as a standard protocol
which was first repoted by Liu Y [16]. Skin tissue was
obtained from the back of neonatal SD rats by plastic
surgical procedures and was washed in phosphate-
buffered solution (PBS). Connective tissue and subcuta-
neous fat were removed. The skin sample was sterilized
with 70% ethanol for 5 min, rinsed in PBS, and minced
into 5-mm wide strips using a sharp scalpel; the strips
were treated with 0.25% Dispase (Roche, Switzerland)
solution at 4°C overnight. The epidermis was mechanic-
ally separated from the dermis and incubated in 0.25%
trypsin solution at 37°C for 15 min to dissociate the
cells; enzyme activity was then blocked with Dulbecco’s
modified Eagle’s medium (DMEM; Gibco, USA) contain-
ing 10% fetal bovine serum (FBS; Gibco, USA), and the
cells were suspended with a pipette. To remove any
remaining tissue pieces, the cell suspension was filtered
through a stainless steel mesh attached to a 60-mm cell
culture plate. The cells were transferred to a 15-ml cen-
trifuge tube and collected by centrifugation for 5 min at
250 g. To select stem cells, 1x106 dissociated epidermal
cells were plated onto collagen type IV (Sigma, USA)
(100 μg/ml)-coated dishes at room temperature for
15 min. The unattached cells were removed, and the
rapidly adherent epidermal cells were cultured with
keratinocyte serum-free medium (K-SFM; Gibco, USA)
supplemented with epidermal growth factor (EGF) (K-
SFM; Gibco, USA), bovine pituitary extract (BPE; Gibco,
USA), and 0.05 mM calcium chloride (CaCl2, Sigma,
USA) at 37°C under 5% CO2 in a humidified incubator
for two days before replacing the medium. The medium
was changed every other day.
Lentivirus vector construction and EpSC infection
The coding sequence of rat Nanog was PCR amplified
from GV208: rat-Nanog using primers with AgeI/AgeI
overhangs and was cloned into pTZ58 (Fermentas, Vilnus,
Lithuania). The AgeI/AgeI fragment was then sub-cloned
into pUbi (AgeI/AgeI) and pEGFP-C1 (Clontech, Mountain
View, CA) (AgeI/AgeI) to generate Ubi-Nanog-EGFP
encoding plasmids, respectively. To produce lentivirus,
the pBABE-puro plasmids were co-infected along with the
helper plasmids into 293 T cells, and the medium was har-
vested 36 h and 72 h after infection. EpSC infection was
performed by incubating the cells in virus-enriched
medium for 12 h, which included 4 μg/ml polybrene.
Transduced cells were identified for EGFP expression
under a fluorescence microscope. The transduced EpSCs
were divided into two groups: the first group of EpSCs
was treated with SP for 12 days after infection; the second
group of EpSCs was cultured for 12 days. EpSCs were alsoinfected with control lentivirus vector and cultured for
12 days. EpSCs without any treatment were used as
control.
Immunofluorescence
The isolated cells were cultured in a 6-well plate (104
cells/well) for 24 h. The cells were rinsed five times with
PBS, fixed with 4% paraformaldehyde solution for
15 min at room temperature, and permeated with 0.5%
Triton X-100-PBS solution for 5 min. After blocking
with 3% BSA in PBS for 30 min, the cells were respect-
ively incubated with primary antibodies to anti-CD 34
antibody (rabbit polyclonal antibody, 1:50, Santa Cruz
Biotechnology, Inc.) and anti-β1 integrin antibody
(rabbit polyclonal antibody, 1:50, Boster Biological Tech-
nology, Ltd.) at 4°C overnight. The primary antibody
binding was detected via the corresponding goat anti-
rabbit IgG: Cy3 and goat anti-mouse IgG FITC (Boster
Biological Technology, Ltd.). Staining was examined
under a fluorescence microscope.
Immunocytochemistry
The isolated cells were cultured in a 6-well plate (104
cells/well) for 24 h. The cells were treated with 10−7 M
SP or LiCl, a Wnt agonist, to induce differentiation for
12 days. The cells were rinsed five times with PBS, fixed
with 4% paraformaldehyde solution for 15 min at room
temperature, and permeated with 0.5% Triton X-100-
PBS solution for 5 min. The cells were incubated with
primary antibodies to anti-cytokeratin 18 antibody
(CK18) (rabbit polyclonal antibody, 1:50, Santa Cruz
Biotechnology, Inc.) at 4°C overnight. Subsequent proce-
dures were performed according to the SP-9000
Histostain-Plus Kit instructions (ZSGB-BIO, Beijing,
China). The cells were observed under a microscope
(Bio-Rad, Hercules, CA, USA).
Cell Counting Kit-8 (CCK-8) assay
EpSCs were plated in 96-well plates (2 × 104 cells/well)
and treated with collagen type IV. The cells were then
divided into four groups: the first group was composed
of cells without any treatment, the second group was
composed of cells infected with control lentivirus vector,
the third group was composed of transduced cells, and
the forth group was composed of cells that were exposed
to 10−7 M SP. Every other day after day 2 until day 12
post-treatment, 10 μL of CCK-8 (Boster, China) solu-
tions were added to each well, and the samples were in-
cubated for 2 h. The specific absorbance at 450 nm
(A450) was determined using a Micro-plate Reader
(Thermo Fisher, USA). All of the experiments were re-
peated independently at least three times, and each
measurement was the average of 5 duplicate wells.
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The total cell lysates of EpSCs that underwent the prolif-
eration and differentiation were obtained by lysing the
cells in RIPA buffer (Boster, China) containing 50 mM
Tris–HCl, 150 mM NaCl, 1% NP-40, 0.1% SDS, 0.5% so-
dium deoxycholate, 2 mM sodium fluoride, 1 mM
EDTA, 1 mM EGTA and a protease inhibitor cocktail.
The protein concentration was determined using the
bicinchoninic acid protein assay (Beyotime, China). The
proteins were separated by SDS-PAGE, transferred to
nitrocellulose, blocked with bovine serum albumin and
incubated with the following primary antibodies: rat
anti-β-catenin (CST, USA) diluted 1:1000, rat anti-p-β-
catenin (CST, USA) diluted 1:1000, rat anti-c-myc (CST,
USA) diluted 1:1000, rat anti-Nanog (CST, USA) diluted
1:2000, rat anti-GSK3β (CST, USA) diluted 1:1000, rat
anti-p-GSK3β (CST, USA) diluted 1:1000 or rat anti-
GAPDH (Beijing Biosynthesis Biotechnology, China) di-
luted 1:1000 that was used as a loading control. The
membrane was washed and incubated with the respect-
ive secondary antibodies conjugated with peroxidase.
Chemiluminescence (Bio-Rad, USA) was used to detect
protein.Real-time quantitative PCR
Total RNA was extracted using the TRIzol reagent
(Invitrogen, USA), according to the manufacturer’s proto-
col. Using a spectrophotometer (Eppendorf, Germany), the
RNA concentration and purity were determined by A260
and A260/A280 ratios, respectively. Total RNA was used
to synthesize cDNA with a Super-Script II cDNA syn-
thesis kit (Invitrogen Life Technologies, USA). The re-
lated genes of the Wnt/β-catenin signaling pathway
and Nanog were assessed by quantitative real-time PCR
using a SYBR-Green Master mix (Fermentas, Vilnius,
Lithuania). Glyceraldehyde phosphate dehydrogenase
(GAPDH) was selected as an internal control. The pri-
mer sequences are: Nanog (accession no. NM_0011
00781) forward, CCGTTGGGCTGACATGAGCGT and
reverse, GGCAGGCATCGGCGAGGAAT; β-catenin
(accession no. NM_053357) forward, AGCCCGTTG-
TACCGCTGGGA and reverse, CGCTGGGATGCCGC-
CAGATT; c-myc (accession no. NM_012603) forward,
CATCATCCAGGACTGTATGTG and reverse, TGGA
ATCGGACGAGGTA; GAPDH (accession no. NM_0170
08) forward, TATGACTCTACCCACGGCAAGT and re-
verse, ATACTCAGCACCAGCATCACC.Statistical analysis
All experiments were repeated independently at least three
times. The data are presented as the mean ± standard de-
viation (SD). The results were analyzed using SPSS 18.0
statistical software. Statistically significant differences wereidentified using Student’s t-test and an analysis of variance
(ANOVA). The significance level was set to P < 0.05.
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